Literature DB >> 19433916

Mutant HFE genotype leads to significant iron overload in patients with liver diseases from western Romania.

A-M Neghina1, A Anghel, I Sporea, A Popescu, R Neghina, A Collins, K Thorstensen.   

Abstract

The present study aimed at assessing the frequency of HFE mutations (C282Y, H63D and S65C) in western Romanian patients with liver disease of diverse aetiologies suspected of iron overload. A total of 21 patients, all Romanian residents hospitalized with clinical suspicion of iron overload and liver disease, were assayed for C282Y, H63D and S65C mutations, serum ferritin and viral hepatitis markers. Overall, 9 out of the 21 patients (42.86%) were found to harbour mutations in the HFE gene: 4 homozygotes C282Y (19.0%), 1 compound heterozygote C282Y/H63D (4.8%), 1 single heterozygote C282Y (4.8%), 2 single heterozygotes H63D (9.5%), 1 single heterozygote S65C (4.8%), and 12 wild-type cases (57.1%). Among the subgroup of 10 patients with the most prominent signs of iron overload (hyperferritinaemia and/or hepatocyte iron score > or = 1), without hepatocellular carcinoma, the HFE genotypes were conclusive in 5 cases (50%). They had significantly increased ferritin levels compared to wild-type cases (P = 0.029). The inclusion of iron studies during routine clinical visits, coupled with the availability of HFE genotyping for family and population studies, should facilitate the early detection of hereditary haemochromatosis in Romania.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19433916     DOI: 10.1007/BF03195670

Source DB:  PubMed          Journal:  J Appl Genet        ISSN: 1234-1983            Impact factor:   3.240


  10 in total

1.  LightCycler PCR assay for simultaneous detection of the H63D and S65C mutations in the HFE hemochromatosis gene based on opposite melting temperature shifts.

Authors:  M Bollhalder; C Mura; O Landt; F E Maly
Journal:  Clin Chem       Date:  1999-12       Impact factor: 8.327

2.  Polymorphism in intron 4 of HFE may cause overestimation of C282Y homozygote prevalence in haemochromatosis.

Authors:  G P Jeffrey; S Chakrabarti; R A Hegele; P C Adams
Journal:  Nat Genet       Date:  1999-08       Impact factor: 38.330

3.  Rapid genotyping of hemochromatosis gene mutations on the LightCycler with fluorescent hybridization probes.

Authors:  K Mangasser-Stephan; C Tag; A Reiser; A M Gressner
Journal:  Clin Chem       Date:  1999-10       Impact factor: 8.327

4.  A novel MHC class I-like gene is mutated in patients with hereditary haemochromatosis.

Authors:  J N Feder; A Gnirke; W Thomas; Z Tsuchihashi; D A Ruddy; A Basava; F Dormishian; R Domingo; M C Ellis; A Fullan; L M Hinton; N L Jones; B E Kimmel; G S Kronmal; P Lauer; V K Lee; D B Loeb; F A Mapa; E McClelland; N C Meyer; G A Mintier; N Moeller; T Moore; E Morikang; C E Prass; L Quintana; S M Starnes; R C Schatzman; K J Brunke; D T Drayna; N J Risch; B R Bacon; R K Wolff
Journal:  Nat Genet       Date:  1996-08       Impact factor: 38.330

5.  Frequency of the hemochromatosis gene mutations in the population of Serbia and Montenegro.

Authors:  M Sarić; Lj Zamurović; M Keckarević-Marković; D Keckarević; M Stevanović; D Savić-Pavićević; J Jović; S Romac
Journal:  Clin Genet       Date:  2006-08       Impact factor: 4.438

6.  Incidence of the HFE gene mutations in a cohort of non-Spanish origin neonates in Madrid.

Authors:  Paloma Ropero; Leopoldo Llorente; Fernando A González; Olga Briceño; Marta Mateo; Marta Polo; Ana Villegas
Journal:  Ann Hematol       Date:  2007-02-06       Impact factor: 3.673

7.  The effects of wild-type and mutant HFE expression upon cellular iron uptake in transfected human embryonic kidney cells.

Authors:  G P Feeney; M Worwood
Journal:  Biochim Biophys Acta       Date:  2001-04-23

8.  Hemochromatosis genotypes and risk of 31 disease endpoints: meta-analyses including 66,000 cases and 226,000 controls.

Authors:  Christina Ellervik; Henrik Birgens; Anne Tybjaerg-Hansen; Børge G Nordestgaard
Journal:  Hepatology       Date:  2007-10       Impact factor: 17.425

9.  Biological variability of transferrin saturation and unsaturated iron-binding capacity.

Authors:  Paul C Adams; David M Reboussin; Richard D Press; James C Barton; Ronald T Acton; Godfrey C Moses; Catherine Leiendecker-Foster; Gordon D McLaren; Fitzroy W Dawkins; Victor R Gordeuk; Laura Lovato; John H Eckfeldt
Journal:  Am J Med       Date:  2007-11       Impact factor: 4.965

Review 10.  Current approach to hemochromatosis.

Authors:  Pierre Brissot; Marie-Bérengère Troadec; Edouard Bardou-Jacquet; Caroline Le Lan; Anne-Marie Jouanolle; Yves Deugnier; Olivier Loréal
Journal:  Blood Rev       Date:  2008-04-21       Impact factor: 8.250

  10 in total
  3 in total

1.  Low frequency of HFE gene mutations in Croatian patients suspected of having hereditary hemochromatosis.

Authors:  Sandra Milić; Smiljana Ristić; Nada Starčević-Čizmarević; Bojana Brajenović-Milić; Marija Crnić-Martinović; Miljenko Kapović; Borut Peterlin; Davor Štimac
Journal:  Med Sci Monit       Date:  2011-10

2.  Frequency of Two Common HFE Gene Mutations (C282Y and H63D) in a Group of Iranian Patients With Cryptogenic Cirrhosis.

Authors:  Zahra Jowkar; Bita Geramizadeh; Mahmoud Shariat
Journal:  Hepat Mon       Date:  2011-11-30       Impact factor: 0.660

3.  Association between the HFE C282Y, H63D Polymorphisms and the Risks of Non-Alcoholic Fatty Liver Disease, Liver Cirrhosis and Hepatocellular Carcinoma: An Updated Systematic Review and Meta-Analysis of 5,758 Cases and 14,741 Controls.

Authors:  Qing Ye; Bao-Xin Qian; Wei-Li Yin; Feng-Mei Wang; Tao Han
Journal:  PLoS One       Date:  2016-09-22       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.